Skip to content

Investigator

Alex Rojas Bie Thomsen

UNCO THERAPEUTICS LLC · funded by NIGMS

Companies
1

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$753k

Summed across those awards.

First award
Sep 1, 2022

Latest Sep 16, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R41

    Development of Allosteric Uncouplers as Therapeutics for Chronic Pain

    $350k

    Sep 16, 2025NIGMSUNCO THERAPEUTICS LLCNIH RePORTER · 11253679 (opens the source filing in a new tab)

  2. R35

    Spatiotemporal Regulation of GPCR Signaling by Different Beta-Arrestin Conformations

    $403k

    Sep 1, 2022NIGMSNEW YORK UNIVERSITYNIH RePORTER · 11190936 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources